The Humanized Liver Mice Model Market To Bank On Its Armory Of Product/Service O

Posted by Ashish on January 18th, 2021

A large number of humanized liver mice models are available, including uPA-SCID mice, FRG KO mice, and TK-NOG mice, among others. Factors such as increasing incidence of liver cirrhosis, technological advancement and development of new humanized liver mice models, increase in number of FDA approvals for liver-based disease treatment dugs have increased the number of research and development activities, which require these models.

However, the high cost of mice models as well as high shipping cost, and availability of alternatives are factors expected to hinder the growth of the humanized liver mice model market during the forecast period. Furthermore, regulatory challenges including patenting of mice and other ethical issues including the use of 3Rs policy are also expected to restrain the growth of the humanized liver mice model market.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/25417

Company Profiles

• Taconic Biosciences, Inc.
• Beijing Vitalstar Biotechnology Co., Ltd.
• Yecuris Corporation
• PhoenixBio Group
• In-Vivo Science Inc.
• The Jackson Laboratory
• University of Massachusetts Medical School(Mueller Lab)
• Oncodesign
• University of Nebraska Medical Center